{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35746960", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "27"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "14"}], "Language": ["eng"], "ELocationID": ["3777021", "10.1155/2022/3777021"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease.", "Pagination": {"StartPage": "3777021", "MedlinePgn": "3777021"}, "Abstract": {"AbstractText": ["Aging is associated with the occurrence of diverse degenerative changes in various tissues and organs and with an increased incidence of neurological disorders, especially neurodegenerative diseases such as Alzheimer's disease (AD). In recent years, the search for effective components derived from medicinal plants in delaying aging and preventing and treating neurodegenerative diseases has been increasing and the number of related publications shows a rising trend. Here, we present a concise, updated review on the preclinical and clinical research progress in the assessment of the therapeutic potential of different traditional Chinese medicines and derived active ingredients and their effect on the signaling pathways involved in AD neuroprotection. Recognized by their multitargeting ability, these natural compounds hold great potential in developing novel drugs for AD."], "CopyrightInformation": "Copyright \u00a9 2022 Qin Li et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Reproduction, Development and Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, China."}], "LastName": "Li", "ForeName": "Qin", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 9112001, Israel."}], "LastName": "Rubin", "ForeName": "Limor", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Reproduction, Development and Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China."}, {"Identifier": [], "Affiliation": "MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China."}], "LastName": "Silva", "ForeName": "Marta", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Reproduction, Development and Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China."}, {"Identifier": [], "Affiliation": "MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China."}, {"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China."}], "LastName": "Li", "ForeName": "Shuai", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Reproduction, Development and Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China."}, {"Identifier": [], "Affiliation": "MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China."}], "LastName": "Yang", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacology, School of Pharmacy Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel."}], "LastName": "Lazarovici", "ForeName": "Philip", "Initials": "P"}, {"Identifier": ["0000-0001-9014-0055"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Reproduction, Development and Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China."}, {"Identifier": [], "Affiliation": "MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China."}], "LastName": "Zheng", "ForeName": "Wenhua", "Initials": "W"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Artemisia"}, {"QualifierName": [], "DescriptorName": "Astragalus Plant"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Ginkgo biloba"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": [], "DescriptorName": "Neuroprotection"}, {"QualifierName": [], "DescriptorName": "Panax"}], "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Athar T., Al Balushi K., Khan S. Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease. Molecular biology reports. . 2021;48(7):5629\u20135645. doi: 10.1007/s11033-021-06512-9.", "ArticleIdList": ["10.1007/s11033-021-06512-9", "PMC8236749", "34181171"]}, {"Citation": "Mendiola-Precoma J., Berumen L., Padilla K., Garcia-Alcocer G. Therapies for Prevention and Treatment of Alzheimer\u2019s Disease. BioMed research international. . 2016;2016, article 2589276:1\u201317. doi: 10.1155/2016/2589276.", "ArticleIdList": ["10.1155/2016/2589276", "PMC4980501", "27547756"]}, {"Citation": "Mebane-Sims I. 2020 Alzheimer's disease facts and figures. Alzheimer's & Dementia . 2020;16(3):391\u2013460."}, {"Citation": "Hampel H., Mesulam M., Cuello A., et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain : a journal of neurology . 2018;141(7):1917\u20131933. doi: 10.1093/brain/awy132.", "ArticleIdList": ["10.1093/brain/awy132", "PMC6022632", "29850777"]}, {"Citation": "Trejo-Lopez J., Yachnis A., Prokop S. Neuropathology of Alzheimer's disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics . 2022;19(1):173\u2013185. doi: 10.1007/s13311-021-01146-y.", "ArticleIdList": ["10.1007/s13311-021-01146-y", "PMC9130398", "34729690"]}, {"Citation": "Weiner M., Veitch D., Aisen P., et al. Recent publications from the Alzheimer's disease neuroimaging initiative: reviewing progress toward improved AD clinical trials. Alzheimer's & dementia : the journal of the Alzheimer's Association . 2017;13(4):e1\u2013e85. doi: 10.1016/j.jalz.2016.11.007.", "ArticleIdList": ["10.1016/j.jalz.2016.11.007", "PMC6818723", "28342697"]}, {"Citation": "Hampel H., Caraci F., Cuello A., et al. A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease. Frontiers in immunology . 2020;11:p. 456. doi: 10.3389/fimmu.2020.00456.", "ArticleIdList": ["10.3389/fimmu.2020.00456", "PMC7137904", "32296418"]}, {"Citation": "Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in pharmacology . 2014;4:p. 177. doi: 10.3389/fphar.2013.00177.", "ArticleIdList": ["10.3389/fphar.2013.00177", "PMC3887317", "24454289"]}, {"Citation": "Singh A., Rai S., Maurya A., et al. Therapeutic Potential of Phytoconstituents in Management of Alzheimer\u2019s Disease. Evidence-based complementary and alternative medicine : eCAM . 2021;2021, article 5578574:1\u201319. doi: 10.1155/2021/5578574.", "ArticleIdList": ["10.1155/2021/5578574", "PMC8208882", "34211570"]}, {"Citation": "Pei H., Ma L., Cao Y., et al. Traditional Chinese medicine for Alzheimer's disease and other cognitive impairment: a review. The American journal of Chinese medicine . 2020;48(3):487\u2013511. doi: 10.1142/S0192415X20500251.", "ArticleIdList": ["10.1142/S0192415X20500251", "32329645"]}, {"Citation": "Jarrell J., Gao L., Cohen D., Huang X. Network medicine for Alzheimer's disease and traditional Chinese medicine. Molecules (Basel, Switzerland) . 2018;23(5):p. 1143. doi: 10.3390/molecules23051143.", "ArticleIdList": ["10.3390/molecules23051143", "PMC6099497", "29751596"]}, {"Citation": "Howes M., Fang R., Houghton P. Effect of Chinese herbal medicine on Alzheimer's disease. International review of neurobiology . 2017;135:29\u201356. doi: 10.1016/bs.irn.2017.02.003.", "ArticleIdList": ["10.1016/bs.irn.2017.02.003", "28807163"]}, {"Citation": "Yang W., Zheng X., Chen S., et al. Chinese herbal medicine for Alzheimer's disease: clinical evidence and possible mechanism of neurogenesis. Biochemical pharmacology . 2017;141:143\u2013155. doi: 10.1016/j.bcp.2017.07.002.", "ArticleIdList": ["10.1016/j.bcp.2017.07.002", "28690138"]}, {"Citation": "Ayaz M., Sadiq A., Junaid M., Ullah F., Subhan F., Ahmed J. Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Frontiers in aging neuroscience . 2017;9:p. 168. doi: 10.3389/fnagi.2017.00168.", "ArticleIdList": ["10.3389/fnagi.2017.00168", "PMC5447774", "28611658"]}, {"Citation": "Akram M., Nawaz A. Effects of medicinal plants on Alzheimer's disease and memory deficits. Neural regeneration research . 2017;12(4):660\u2013670. doi: 10.4103/1673-5374.205108.", "ArticleIdList": ["10.4103/1673-5374.205108", "PMC5436367", "28553349"]}, {"Citation": "Sun Z., Yang H., Chen S. Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease. Translational neurodegeneration . 2013;2(1):p. 6. doi: 10.1186/2047-9158-2-6.", "ArticleIdList": ["10.1186/2047-9158-2-6", "PMC3599149", "23445907"]}, {"Citation": "Wu T., Chen C., Chen C., Jinn T. Traditional Chinese medicines and Alzheimer's disease. Taiwanese journal of obstetrics & gynecology . 2011;50(2):131\u2013135. doi: 10.1016/j.tjog.2011.04.004.", "ArticleIdList": ["10.1016/j.tjog.2011.04.004", "21791295"]}, {"Citation": "Iyaswamy A., Krishnamoorthi S., Song J., et al. NeuroDefend, a novel Chinese medicine, attenuates amyloid-\u03b2 and tau pathology in experimental Alzheimer's disease models. Journal of food and drug analysis . 2020;28(1):132\u2013146. doi: 10.1016/j.jfda.2019.09.004.", "ArticleIdList": ["10.1016/j.jfda.2019.09.004", "31883601"]}, {"Citation": "Graham W., Bonito-Oliva A., Sakmar T. Update on Alzheimer's disease therapy and prevention strategies. Annual review of medicine . 2017;68(1):413\u2013430. doi: 10.1146/annurev-med-042915-103753.", "ArticleIdList": ["10.1146/annurev-med-042915-103753", "28099083"]}, {"Citation": "Selkoe D., Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO molecular medicine . 2016;8(6):595\u2013608. doi: 10.15252/emmm.201606210.", "ArticleIdList": ["10.15252/emmm.201606210", "PMC4888851", "27025652"]}, {"Citation": "Hardy J., Selkoe D. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (New York, NY) . 2002;297(5580):353\u2013356. doi: 10.1126/science.1072994.", "ArticleIdList": ["10.1126/science.1072994", "12130773"]}, {"Citation": "McCarthy J., Twomey C., Wujek P. Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity. Cellular and molecular life sciences : CMLS . 2009;66(9):1534\u20131555. doi: 10.1007/s00018-009-8435-9.", "ArticleIdList": ["10.1007/s00018-009-8435-9", "19189053"]}, {"Citation": "Hung S., Fu W. Drug candidates in clinical trials for Alzheimer's disease. Journal of biomedical science . 2017;24(1):p. 47. doi: 10.1186/s12929-017-0355-7.", "ArticleIdList": ["10.1186/s12929-017-0355-7", "PMC5516350", "28720101"]}, {"Citation": "\u0160imi\u0107 G., Babi\u0107 Leko M., Wray S., et al. Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules . 2016;6(1):p. 6. doi: 10.3390/biom6010006.", "ArticleIdList": ["10.3390/biom6010006", "PMC4808800", "26751493"]}, {"Citation": "Shi M., Chai Y., Zhang J., Chen X. Endoplasmic reticulum stress-associated neuronal death and innate immune response in neurological diseases. Frontiers in immunology . 2022;12, article 794580 doi: 10.3389/fimmu.2021.794580.", "ArticleIdList": ["10.3389/fimmu.2021.794580", "PMC8784382", "35082783"]}, {"Citation": "Singh R., Kaur N., Dhingra N., Kaur T. Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer's disease. The International journal of neuroscience . 2022;1-32:1\u201321. doi: 10.1080/00207454.2021.1968859.", "ArticleIdList": ["10.1080/00207454.2021.1968859", "34402740"]}, {"Citation": "Panza F., Solfrizzi V., Seripa D., et al. Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer\u2019s Disease. BioMed research international . 2016;2016:15. doi: 10.1155/2016/3245935.32459353245935", "ArticleIdList": ["10.1155/2016/3245935", "PMC4939203", "27429978"]}, {"Citation": "Chen Q., Kang J., Caiyun F. The independence of and associations among apoptosis, autophagy, and necrosis. Signal transduction and targeted therapy . 2018;3(1):p. 18. doi: 10.1038/s41392-018-0018-5.", "ArticleIdList": ["10.1038/s41392-018-0018-5", "PMC6026494", "29967689"]}, {"Citation": "Richards R. I., Robertson S. A., O'Keefe L. V., et al. The enemy within: innate surveillance-mediated cell death, the common mechanism of neurodegenerative disease. Frontiers in neuroscience . 2016;10:p. 193. doi: 10.3389/fnins.2016.00193.", "ArticleIdList": ["10.3389/fnins.2016.00193", "PMC4862319", "27242399"]}, {"Citation": "Jia D. P., Wang S., Zhang B. C., Fang F. Paraptosis triggers mitochondrial pathway-mediated apoptosis in Alzheimer's disease. Experimental and Therapeutic Medicine . 2015;10(2):804\u2013808. doi: 10.3892/etm.2015.2531.", "ArticleIdList": ["10.3892/etm.2015.2531", "PMC4508972", "26622397"]}, {"Citation": "Pellegrini L., Passer B. J., Tabaton M., Ganjei J. K., D\u2019Adamio L. Alternative, Non-secretase Processing of Alzheimer's \u03b2-Amyloid Precursor Protein during Apoptosis by Caspase-6 and -8. Journal of Biological Chemistry . 1999;274(30):21011\u201321016. doi: 10.1074/jbc.274.30.21011.", "ArticleIdList": ["10.1074/jbc.274.30.21011", "10409650"]}, {"Citation": "Park G., Nhan H. S., Tyan S. H., et al. Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid \u03b2-Protein-Induced Synapse Loss in Alzheimer's Disease. Cell reports . 2020;31(13, article 107839) doi: 10.1016/j.celrep.2020.107839.", "ArticleIdList": ["10.1016/j.celrep.2020.107839", "PMC7375398", "32610140"]}, {"Citation": "Lu D. C., Soriano S., Bredesen D. E., Koo E. H. Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity. Journal of neurochemistry . 2003;87(3):733\u2013741. doi: 10.1046/j.1471-4159.2003.02059.x.", "ArticleIdList": ["10.1046/j.1471-4159.2003.02059.x", "14535955"]}, {"Citation": "Ohyagi Y., Asahara H., Chui D. H., et al. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer\u2019s disease. The FASEB Journal . 2005;19(2):255\u2013257. doi: 10.1096/fj.04-2637fje.", "ArticleIdList": ["10.1096/fj.04-2637fje", "15548589"]}, {"Citation": "Zhang Y., McLaughlin R., Goodyer C., LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. The Journal of cell biology . 2002;156(3):519\u2013529. doi: 10.1083/jcb.200110119.", "ArticleIdList": ["10.1083/jcb.200110119", "PMC2173346", "11815632"]}, {"Citation": "Coornaert I., Puylaert P., Marcasolli G., et al. Impact of myeloid RIPK1 gene deletion on atherogenesis in ApoE-deficient mice. Atherosclerosis . 2021;322:51\u201360. doi: 10.1016/j.atherosclerosis.2021.02.021.", "ArticleIdList": ["10.1016/j.atherosclerosis.2021.02.021", "33706083"]}, {"Citation": "Jayaraman A., Htike T. T., James R., Picon C., Reynolds R. TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus. Acta neuropathologica communications . 2021;9(1):p. 159. doi: 10.1186/s40478-021-01264-w.", "ArticleIdList": ["10.1186/s40478-021-01264-w", "PMC8501605", "34625123"]}, {"Citation": "Tsuchiya K., Nakajima S., Hosojima S., et al. Caspase-1 initiates apoptosis in the absence of gasdermin D. Nature communications . 2019;10(1):p. 2091. doi: 10.1038/s41467-019-09753-2.", "ArticleIdList": ["10.1038/s41467-019-09753-2", "PMC6505044", "31064994"]}, {"Citation": "Voet S., Srinivasan S., Lamkanfi M., van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO molecular medicine . 2019;11(6) doi: 10.15252/emmm.201810248.", "ArticleIdList": ["10.15252/emmm.201810248", "PMC6554670", "31015277"]}, {"Citation": "Han C., Yang Y., Guan Q., et al. New mechanism of nerve injury in Alzheimer's disease: \u03b2-amyloid-induced neuronal pyroptosis. Journal of cellular and molecular medicine . 2020;24(14):8078\u20138090. doi: 10.1111/jcmm.15439.", "ArticleIdList": ["10.1111/jcmm.15439", "PMC7348172", "32521573"]}, {"Citation": "Li Q., Liu Y., Sun M. Autophagy and Alzheimer's disease. Cellular and molecular neurobiology . 2017;37(3):377\u2013388. doi: 10.1007/s10571-016-0386-8.", "ArticleIdList": ["10.1007/s10571-016-0386-8", "27260250"]}, {"Citation": "Yang S. H., Lee D. K., Shin J., et al. Nec-1 alleviates cognitive impairment with reduction of A\u03b2 and tau abnormalities in APP/PS1 mice. EMBO molecular medicine . 2017;9(1):61\u201377. doi: 10.15252/emmm.201606566.", "ArticleIdList": ["10.15252/emmm.201606566", "PMC5210088", "27861127"]}, {"Citation": "Kumar G., Khanum F. Neuroprotective potential of phytochemicals. Pharmacognosy reviews . 2012;6(12):81\u201390. doi: 10.4103/0973-7847.99898.", "ArticleIdList": ["10.4103/0973-7847.99898", "PMC3459459", "23055633"]}, {"Citation": "Longo F., Massa S. Neuroprotective strategies in Alzheimer's disease. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics . 2004;1(1):117\u2013127. doi: 10.1602/neurorx.1.1.117.", "ArticleIdList": ["10.1602/neurorx.1.1.117", "PMC534917", "15717012"]}, {"Citation": "Fairhurst R., Dondorp A. Artemisinin-resistant Plasmodium falciparum malaria. Microbiology spectrum . 2016;4(3) doi: 10.1128/microbiolspec.EI10-0013-2016.", "ArticleIdList": ["10.1128/microbiolspec.EI10-0013-2016", "PMC4992992", "27337450"]}, {"Citation": "Badshah S., Ullah A., Ahmad N., Almarhoon Z., Mabkhot Y. Increasing the strength and production of artemisinin and its derivatives. Molecules (Basel, Switzerland) . 2018;23(1):p. 100. doi: 10.3390/molecules23010100.", "ArticleIdList": ["10.3390/molecules23010100", "PMC6017432", "29301383"]}, {"Citation": "Ma N., Zhang Z., Liao F., Jiang T., Tu Y. The birth of artemisinin. Pharmacology & therapeutics . 2020;216, article 107658 doi: 10.1016/j.pharmthera.2020.107658.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107658", "32777330"]}, {"Citation": "Martino E., Tarantino M., Bergamini M., et al. Artemisinin and its derivatives; ancient tradition inspiring the latest therapeutic approaches against malaria. Future medicinal chemistry . 2019;11(12):1443\u20131459. doi: 10.4155/fmc-2018-0337.", "ArticleIdList": ["10.4155/fmc-2018-0337", "31298579"]}, {"Citation": "Kumari A., Karnatak M., Singh D., et al. Current scenario of artemisinin and its analogues for antimalarial activity. European journal of medicinal chemistry . 2019;163:804\u2013829. doi: 10.1016/j.ejmech.2018.12.007.", "ArticleIdList": ["10.1016/j.ejmech.2018.12.007", "30579122"]}, {"Citation": "Patel O., Beteck R., Legoabe L. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research. European journal of medicinal chemistry . 2021;213, article 113193 doi: 10.1016/j.ejmech.2021.113193.", "ArticleIdList": ["10.1016/j.ejmech.2021.113193", "33508479"]}, {"Citation": "Zuo S., Ge H., Li Q., et al. Artesunate protected blood-brain barrier via sphingosine 1 phosphate receptor 1/phosphatidylinositol 3 kinase pathway after subarachnoid hemorrhage in rats. Molecular neurobiology . 2017;54(2):1213\u20131228. doi: 10.1007/s12035-016-9732-6.", "ArticleIdList": ["10.1007/s12035-016-9732-6", "26820677"]}, {"Citation": "Ho W., Peh H., Chan T., Wong W. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacology & therapeutics . 2014;142(1):126\u2013139. doi: 10.1016/j.pharmthera.2013.12.001.", "ArticleIdList": ["10.1016/j.pharmthera.2013.12.001", "24316259"]}, {"Citation": "Lu B., Baum L., So K., Chiu K., Xie L. More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration. Neural regeneration research . 2019;14(9):1494\u20131498. doi: 10.4103/1673-5374.255960.", "ArticleIdList": ["10.4103/1673-5374.255960", "PMC6557089", "31089038"]}, {"Citation": "Zheng W., Chong C.-M., Wang H., et al. Artemisinin conferred ERK mediated neuroprotection to PC12 cells and cortical neurons exposed to sodium nitroprusside-induced oxidative insult. Free Radical Biology and Medicine . 2016;97:158\u2013167. doi: 10.1016/j.freeradbiomed.2016.05.023.", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.05.023", "27242266"]}, {"Citation": "Zhao X., Fang J., Li S., et al. Artemisinin attenuated hydrogen peroxide (H2O2)-Induced oxidative injury in SH-SY5Y and hippocampal neurons via the activation of AMPK pathway. International journal of molecular sciences . 2019;20(11):p. 2680. doi: 10.3390/ijms20112680.", "ArticleIdList": ["10.3390/ijms20112680", "PMC6600327", "31151322"]}, {"Citation": "Zeng Z., Xu J., Zheng W. Artemisinin protects PC12 cells against \u03b2-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. Redox biology . 2017;12:625\u2013633. doi: 10.1016/j.redox.2017.04.003.", "ArticleIdList": ["10.1016/j.redox.2017.04.003", "PMC5385605", "28391183"]}, {"Citation": "Lin S., Li W., Winters A., Liu R., Yang S. Artemisinin prevents glutamate-induced neuronal cell death via Akt pathway activation. Frontiers in cellular neuroscience . 2018;12:p. 108. doi: 10.3389/fncel.2018.00108.", "ArticleIdList": ["10.3389/fncel.2018.00108", "PMC5919952", "29731711"]}, {"Citation": "Li S., Zhao X., Lazarovici P., Zheng W. Artemether Activation of AMPK/GSK3\u03b2(ser9)/Nrf2 Signaling Confers Neuroprotection towards \u03b2-Amyloid-Induced Neurotoxicity in 3xTg Alzheimer\u2019s Mouse Model. Oxidative medicine and cellular longevity . 2019;2019:24. doi: 10.1155/2019/1862437.1862437", "ArticleIdList": ["10.1155/2019/1862437", "PMC6907052", "31871541"]}, {"Citation": "Zhao X., Li S., Gaur U., Zheng W. Artemisinin improved neuronal functions in Alzheimer's disease animal model 3xtg mice and neuronal cells via stimulating the ERK/CREB signaling pathway. Aging and disease . 2020;11(4):801\u2013819. doi: 10.14336/AD.2019.0813.", "ArticleIdList": ["10.14336/AD.2019.0813", "PMC7390534", "32765947"]}, {"Citation": "Xia L., Pang Y., Li J., et al. Dihydroartemisinin induces O-GlcNAcylation and improves cognitive function in a mouse model of tauopathy. Journal of Alzheimer's disease : JAD . 2021;84(1):239\u2013248. doi: 10.3233/JAD-210643.", "ArticleIdList": ["10.3233/JAD-210643", "34511503"]}, {"Citation": "Okorji U., Olajide O. A semi-synthetic derivative of artemisinin, artesunate inhibits prostaglandin E2 production in LPS/IFN\u03b3-activated BV2 microglia. Bioorganic & medicinal chemistry . 2014;22(17):4726\u20134734. doi: 10.1016/j.bmc.2014.07.007.", "ArticleIdList": ["10.1016/j.bmc.2014.07.007", "25074847"]}, {"Citation": "Lee I., Ryu D., Lim J., Cho S., Kang B., Choi H. Artesunate activates Nrf2 pathway-driven anti-inflammatory potential through ERK signaling in microglial BV2 cells. Neuroscience letters . 2012;509(1):17\u201321. doi: 10.1016/j.neulet.2011.12.034.", "ArticleIdList": ["10.1016/j.neulet.2011.12.034", "22227297"]}, {"Citation": "Wang D., Shi J., Lv S., et al. Artesunate attenuates lipopolysaccharide-stimulated proinflammatory responses by suppressing TLR4, MyD88 expression, and NF-\u03baB activation in microglial cells. Inflammation . 2015;38(5):1925\u20131932. doi: 10.1007/s10753-015-0172-7.", "ArticleIdList": ["10.1007/s10753-015-0172-7", "26002587"]}, {"Citation": "Li H., Wang T., Hou C., et al. Artemether attenuates A\u03b225-35-induced cognitive impairments by downregulating A\u03b2, BACE1, mTOR and Tau proteins. Clinical laboratory . 2021;67(10/2021) doi: 10.7754/Clin.Lab.2021.201212.", "ArticleIdList": ["10.7754/Clin.Lab.2021.201212", "34655202"]}, {"Citation": "Qiang W., Cai W., Yang Q., et al. Artemisinin B improves learning and memory impairment in AD dementia mice by suppressing neuroinflammation. Neuroscience . 2018;395:1\u201312. doi: 10.1016/j.neuroscience.2018.10.041.", "ArticleIdList": ["10.1016/j.neuroscience.2018.10.041", "30399421"]}, {"Citation": "Bauzon J., Lee G., Cummings J. Repurposed agents in the Alzheimer's disease drug development pipeline. Alzheimer's research & therapy . 2020;12(1):p. 98. doi: 10.1186/s13195-020-00662-x.", "ArticleIdList": ["10.1186/s13195-020-00662-x", "PMC7433208", "32807237"]}, {"Citation": "Zheng M., Xin Y., Li Y., et al. Ginsenosides: a potential neuroprotective agent. BioMed research international . 2018;2018:11. doi: 10.1155/2018/8174345.8174345", "ArticleIdList": ["10.1155/2018/8174345", "PMC5964429", "29854792"]}, {"Citation": "Li F., Wu X., Li J., Niu Q. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model. Molecular medicine reports . 2016;13(6):4904\u20134910. doi: 10.3892/mmr.2016.5103.", "ArticleIdList": ["10.3892/mmr.2016.5103", "27082952"]}, {"Citation": "Cho I. Effects of Panax ginseng in neurodegenerative diseases. Journal of ginseng research . 2012;36(4):342\u2013353. doi: 10.5142/jgr.2012.36.4.342.", "ArticleIdList": ["10.5142/jgr.2012.36.4.342", "PMC3659610", "23717136"]}, {"Citation": "Huang X., Li N., Pu Y., Zhang T., Wang B. Neuroprotective effects of ginseng phytochemicals: recent perspectives. Molecules (Basel, Switzerland) . 2019;24(16):p. 2939. doi: 10.3390/molecules24162939.", "ArticleIdList": ["10.3390/molecules24162939", "PMC6720911", "31416121"]}, {"Citation": "Rajabian A., Rameshrad M., Hosseinzadeh H. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review. Expert opinion on therapeutic patents . 2019;29(1):55\u201372. doi: 10.1080/13543776.2019.1556258.", "ArticleIdList": ["10.1080/13543776.2019.1556258", "30513224"]}, {"Citation": "Heo J., Lee S., Chu K., et al. Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease. Nutritional neuroscience . 2012;15(6):278\u2013282. doi: 10.1179/1476830512Y.0000000027.", "ArticleIdList": ["10.1179/1476830512Y.0000000027", "22780999"]}, {"Citation": "Lu Z., Shen Y., Zhang P., et al. Ginsenoside Rg1 promotes proliferation and neurotrophin expression of olfactory ensheathing cells. Journal of Asian natural products research . 2010;12(4):265\u2013272. doi: 10.1080/10286021003689791.", "ArticleIdList": ["10.1080/10286021003689791", "20419536"]}, {"Citation": "Liang W., Ge S., Yang L., et al. Ginsenosides Rb1 and Rg1 promote proliferation and expression of neurotrophic factors in primary Schwann cell cultures. Brain research . 2010;1357:19\u201325. doi: 10.1016/j.brainres.2010.07.091.", "ArticleIdList": ["10.1016/j.brainres.2010.07.091", "20682297"]}, {"Citation": "Choi R., Roy A., Jung H., et al. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides. Journal of ethnopharmacology . 2016;190:219\u2013230. doi: 10.1016/j.jep.2016.06.013.", "ArticleIdList": ["10.1016/j.jep.2016.06.013", "27275774"]}, {"Citation": "Ye X., Tai W., Zhang D. The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits. Neurobiology of aging . 2012;33(6):1122.e1\u20131122.e10. doi: 10.1016/j.neurobiolaging.2011.11.004.", "ArticleIdList": ["10.1016/j.neurobiolaging.2011.11.004", "22212405"]}, {"Citation": "Hu W., Feng Z., Xu J., Jiang Z., Feng M. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats. Brain research . 2019;1710:61\u201373. doi: 10.1016/j.brainres.2018.12.034.", "ArticleIdList": ["10.1016/j.brainres.2018.12.034", "30586546"]}, {"Citation": "Jiao S., Shen L., Zhu C., et al. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease. Translational psychiatry . 2016;6(10, article e907) doi: 10.1038/tp.2016.186.", "ArticleIdList": ["10.1038/tp.2016.186", "PMC5315549", "27701410"]}, {"Citation": "Fang F., Chen X., Huang T., Lue L., Luddy J., Yan S. Multi-faced neuroprotective effects of ginsenoside Rg1 in an Alzheimer mouse model. Biochimica et biophysica acta . 2012;1822(2):286\u2013292. doi: 10.1016/j.bbadis.2011.10.004.", "ArticleIdList": ["10.1016/j.bbadis.2011.10.004", "PMC3304026", "22015470"]}, {"Citation": "Liu J., Yan X., Li L., et al. Ginsennoside rd attenuates cognitive dysfunction in a rat model of Alzheimer's disease. Neurochemical research . 2012;37(12):2738\u20132747. doi: 10.1007/s11064-012-0866-2.", "ArticleIdList": ["10.1007/s11064-012-0866-2", "22903450"]}, {"Citation": "Li J., Huang Q., Chen J., et al. Neuroprotective potentials of Panax ginseng against Alzheimer's disease: a review of preclinical and clinical evidences. Frontiers in pharmacology . 2021;12, article 688490 doi: 10.3389/fphar.2021.688490.", "ArticleIdList": ["10.3389/fphar.2021.688490", "PMC8206566", "34149431"]}, {"Citation": "Wang Y., Yang G., Gong J., et al. Ginseng for Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. Current topics in medicinal chemistry . 2016;16(5):529\u2013536. doi: 10.2174/1568026615666150813143753.", "ArticleIdList": ["10.2174/1568026615666150813143753", "26268331"]}, {"Citation": "Heo J., Lee S., Chu K., et al. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. European journal of neurology . 2008;15(8):865\u2013868. doi: 10.1111/j.1468-1331.2008.02157.x.", "ArticleIdList": ["10.1111/j.1468-1331.2008.02157.x", "18684311"]}, {"Citation": "Zhang X., Wu J., Zhang B. Xuesaitong injection as one adjuvant treatment of acute cerebral infarction: a systematic review and meta-analysis. BMC complementary and alternative medicine . 2015;15(1):p. 36. doi: 10.1186/s12906-015-0560-4.", "ArticleIdList": ["10.1186/s12906-015-0560-4", "PMC4355548", "25888429"]}, {"Citation": "Fu J., Wang Z., Huang L., et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi) Phytotherapy research : PTR . 2014;28(9):1275\u20131283. doi: 10.1002/ptr.5188.", "ArticleIdList": ["10.1002/ptr.5188", "25087616"]}, {"Citation": "Jiang B., Xiong Z., Yang J., et al. Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. British journal of pharmacology . 2012;166(6):1872\u20131887. doi: 10.1111/j.1476-5381.2012.01902.x.", "ArticleIdList": ["10.1111/j.1476-5381.2012.01902.x", "PMC3402811", "22335772"]}, {"Citation": "Xu L., Wei K., Jiang J., Zhang L. Extraction optimization of astragaloside IV by response surface methodology and evaluation of its stability during sterilization and storage. Molecules (Basel, Switzerland) . 2021;26(8):p. 2400. doi: 10.3390/molecules26082400.", "ArticleIdList": ["10.3390/molecules26082400", "PMC8074912", "33924283"]}, {"Citation": "Li L., Hou X., Xu R., Liu C., Tu M. Research review on the pharmacological effects of astragaloside IV. Fundamental & clinical pharmacology . 2017;31(1):17\u201336. doi: 10.1111/fcp.12232.", "ArticleIdList": ["10.1111/fcp.12232", "27567103"]}, {"Citation": "Yang J., Li J., Lu J., Zhang Y., Zhu Z., Wan H. Synergistic protective effect of astragaloside IV\u2013tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia. Journal of ethnopharmacology . 2012;140(1):64\u201372. doi: 10.1016/j.jep.2011.12.023.", "ArticleIdList": ["10.1016/j.jep.2011.12.023", "22207211"]}, {"Citation": "Costa I., Lima F., Fernandes L., et al. Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: a systematic review. Current neuropharmacology . 2019;17(7):648\u2013665. doi: 10.2174/1570159X16666180911123341.", "ArticleIdList": ["10.2174/1570159X16666180911123341", "PMC6712289", "30207235"]}, {"Citation": "Wang X., Gao F., Xu W., Cao Y., Wang J., Zhu G. Depichering the effects of astragaloside IV on AD-like phenotypes: a systematic and experimental investigation. Oxidative medicine and cellular longevity . 2021;2021:21. doi: 10.1155/2021/1020614.1020614", "ArticleIdList": ["10.1155/2021/1020614", "PMC8487832", "34616501"]}, {"Citation": "An H., Wei D., Qian Y., Li N., Wang X. SQYZ granules, a traditional Chinese herbal, attenuate cognitive deficits in AD transgenic mice by modulating on multiple pathogenesis processes. American journal of translational research . 2018;10(11):3857\u20133875.", "ArticleIdList": ["PMC6291719", "30662636"]}, {"Citation": "Wang X., Wang Y., Hu J., et al. Astragaloside IV, a natural PPAR\u03b3 agonist, reduces A\u03b2 production in Alzheimer's disease through inhibition of BACE1. Molecular neurobiology . 2017;54(4):2939\u20132949. doi: 10.1007/s12035-016-9874-6.", "ArticleIdList": ["10.1007/s12035-016-9874-6", "27023226"]}, {"Citation": "Yin R., Xue J., Tan Y., et al. The Positive Role and Mechanism of Herbal Medicine in Parkinson\u2019s Disease. Oxidative medicine and cellular longevity . 2021;2021:23. doi: 10.1155/2021/9923331.9923331", "ArticleIdList": ["10.1155/2021/9923331", "PMC8457986", "34567415"]}, {"Citation": "Xu N., Wu X. Research advance of pharmacological effects of astragalosides on nervous system diseases. Zhongguo Zhong yao za zhi= Zhongguo Zhongyao Zazhi= China Journal of Chinese Materia Medica . 2021;46(18):4674\u20134682. doi: 10.19540/j.cnki.cjcmm.20210610.704.", "ArticleIdList": ["10.19540/j.cnki.cjcmm.20210610.704", "34581075"]}, {"Citation": "Xia L., Guo D., Chen B. Neuroprotective effects of astragaloside IV on Parkinson disease models of mice and primary astrocytes. Experimental and therapeutic medicine . 2017;14(6):5569\u20135575. doi: 10.3892/etm.2017.5238.", "ArticleIdList": ["10.3892/etm.2017.5238", "PMC5740776", "29285094"]}, {"Citation": "Li W., Li W., Zhang W., et al. Protective effect of extract of Astragalus on learning and memory impairments and neurons' apoptosis induced by glucocorticoids in 12-month-old male mice. Anatomical record (Hoboken, NJ : 2007) . 2011;294(6):1003\u20131014. doi: 10.1002/ar.21386.", "ArticleIdList": ["10.1002/ar.21386", "21538932"]}, {"Citation": "Chang C., Liu Y., Lin H., et al. Beneficial effect of astragaloside on Alzheimer's disease condition using cultured primary cortical cells under \u03b2-amyloid exposure. Molecular neurobiology . 2016;53(10):7329\u20137340. doi: 10.1007/s12035-015-9623-2.", "ArticleIdList": ["10.1007/s12035-015-9623-2", "26696494"]}, {"Citation": "Haiyan H., Rensong Y., Guoqin J., Xueli Z., Huaying X., Yanwu X. Effect of Astragaloside IV on Neural Stem Cell Transplantation in Alzheimer\u2019s Disease Rat Models. Evidence-based complementary and alternative medicine : eCAM . 2016;2016, article 3106980:1\u20138. doi: 10.1155/2016/3106980.", "ArticleIdList": ["10.1155/2016/3106980", "PMC4806686", "27034688"]}, {"Citation": "Zou C., Liu F., Jiang M., et al. Safety and tolerance of healthy people to injection of astragalosides-a new drug for coronary heart disease. Journal of Sichuan University Medical science edition . 2016;47(5):805\u2013809.", "ArticleIdList": ["28598103"]}, {"Citation": "Chen C. C., Lee H. C., Chang J. H., et al. Chinese herb Astragalus membranaceus enhances recovery of hemorrhagic stroke: double-blind, placebo-controlled, randomized study. Evidence-Based Complementary and Alternative Medicine . 2012;2012:11. doi: 10.1155/2012/708452.708452", "ArticleIdList": ["10.1155/2012/708452", "PMC3310143", "22474516"]}, {"Citation": "Mei N., Guo X., Ren Z., Kobayashi D., Wada K., Guo L. Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. Journal of environmental science and health Part C, Environmental carcinogenesis & ecotoxicology reviews . 2017;35(1):1\u201328. doi: 10.1080/10590501.2016.1278298.", "ArticleIdList": ["10.1080/10590501.2016.1278298", "PMC6373469", "28055331"]}, {"Citation": "van Beek T., Montoro P. Chemical analysis and quality control of _Ginkgo biloba_ leaves, extracts, and phytopharmaceuticals. Journal of chromatography A . 2009;1216(11):2002\u20132032. doi: 10.1016/j.chroma.2009.01.013.", "ArticleIdList": ["10.1016/j.chroma.2009.01.013", "19195661"]}, {"Citation": "EGb 761. Ginkor. Drugs in R&D . 2003;4(3):188\u2013193. doi: 10.2165/00126839-200304030-00009.", "ArticleIdList": ["10.2165/00126839-200304030-00009", "12757407"]}, {"Citation": "M\u00fcller W., Eckert A., Eckert G., et al. Therapeutic efficacy of the Ginkgo special extract EGb761 within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry . 2019;20(3):173\u2013189. doi: 10.1080/15622975.2017.1308552.", "ArticleIdList": ["10.1080/15622975.2017.1308552", "28460580"]}, {"Citation": "Yao Z., Han Z., Drieu K., Papadopoulos V. Ginkgo biloba extract (Egb 761) inhibits \u03b2-amyloid production by lowering free cholesterol levels. The Journal of nutritional biochemistry . 2004;15(12):749\u2013756. doi: 10.1016/j.jnutbio.2004.06.008.", "ArticleIdList": ["10.1016/j.jnutbio.2004.06.008", "15607648"]}, {"Citation": "Luo Y., Smith J., Paramasivam V., et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proceedings of the National Academy of Sciences of the United States of America . 2002;99(19):12197\u201312202. doi: 10.1073/pnas.182425199.", "ArticleIdList": ["10.1073/pnas.182425199", "PMC129421", "12213959"]}, {"Citation": "Qin Y., Zhang Y., Tomic I., et al. Ginkgo biloba extract EGb 761 and its specific components elicit protective protein clearance through the autophagy-lysosomal pathway in tau-transgenic mice and cultured neurons. Journal of Alzheimer's disease : JAD . 2018;65(1):243\u2013263. doi: 10.3233/JAD-180426.", "ArticleIdList": ["10.3233/JAD-180426", "30010136"]}, {"Citation": "Tchantchou F., Lacor P., Cao Z., et al. Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. Journal of Alzheimer's disease : JAD . 2009;18(4):787\u2013798. doi: 10.3233/JAD-2009-1189.", "ArticleIdList": ["10.3233/JAD-2009-1189", "19661619"]}, {"Citation": "Tan M., Yu J., Tan C., et al. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's disease : JAD . 2015;43(2):589\u2013603. doi: 10.3233/JAD-140837.", "ArticleIdList": ["10.3233/JAD-140837", "25114079"]}, {"Citation": "Kandiah N., Chan Y., Chen C., et al. Strategies for the use ofGinkgo bilobaextract, EGb 761\u00ae, in the treatment and management of mild cognitive impairment in Asia: expert consensus. CNS neuroscience & therapeutics . 2021;27(2):149\u2013162. doi: 10.1111/cns.13536.", "ArticleIdList": ["10.1111/cns.13536", "PMC7816207", "33352000"]}, {"Citation": "De Felice F. G., Velasco P. T., Lambert M. P., et al. A\u03b2 Oligomers Induce Neuronal Oxidative Stress through an N -Methyl-D- aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine. The Journal of biological chemistry . 2007;282(15):11590\u201311601. doi: 10.1074/jbc.M607483200.", "ArticleIdList": ["10.1074/jbc.M607483200", "17308309"]}, {"Citation": "Auld D., Kornecook T., Bastianetto S., Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to \u03b2-amyloid peptides, cognition, and treatment strategies. Progress in neurobiology . 2002;68(3):209\u2013245. doi: 10.1016/S0301-0082(02)00079-5.", "ArticleIdList": ["10.1016/S0301-0082(02)00079-5", "12450488"]}, {"Citation": "Terry A., Buccafusco J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. The Journal of pharmacology and experimental therapeutics . 2003;306(3):821\u2013827. doi: 10.1124/jpet.102.041616.", "ArticleIdList": ["10.1124/jpet.102.041616", "12805474"]}, {"Citation": "Parsons C., Danysz W., Dekundy A., Pulte I. Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease. Neurotoxicity research . 2013;24(3):358\u2013369. doi: 10.1007/s12640-013-9398-z.", "ArticleIdList": ["10.1007/s12640-013-9398-z", "PMC3753463", "23657927"]}, {"Citation": "Lopez O., Becker J., Wahed A., et al. Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. Journal of neurology, neurosurgery, and psychiatry . 2009;80(6):600\u2013607. doi: 10.1136/jnnp.2008.158964.", "ArticleIdList": ["10.1136/jnnp.2008.158964", "PMC2823571", "19204022"]}, {"Citation": "Kaufmann D., Kaur Dogra A., Tahrani A., Herrmann F., Wink M. Extracts from traditional Chinese medicinal plants inhibit acetylcholinesterase, a known Alzheimer's disease target. Molecules (Basel, Switzerland) . 2016;21(9):p. 1161. doi: 10.3390/molecules21091161.", "ArticleIdList": ["10.3390/molecules21091161", "PMC6273583", "27589716"]}, {"Citation": "Jiang Y., Gao H., Turdu G. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti- Alzheimer's disease: A review. Bioorganic chemistry . 2017;75:50\u201361. doi: 10.1016/j.bioorg.2017.09.004.", "ArticleIdList": ["10.1016/j.bioorg.2017.09.004", "28915465"]}, {"Citation": "Liu Y., Wang S., Kan J., et al. Chinese herbal medicine interventions in neurological disorder therapeutics by regulating glutamate signaling. Current neuropharmacology . 2020;18(4):260\u2013276. doi: 10.2174/1570159X17666191101125530.", "ArticleIdList": ["10.2174/1570159X17666191101125530", "PMC7327939", "31686629"]}, {"Citation": "Yu Z., Wang B., Yang F., Sun Q., Yang Z., Zhu L. Chemical compositionand anti-acetyl cholinesterase activity of flower essential oils of artemisiaannuaat different flowering stage. Iranian journal of pharmaceutical research : IJPR . 2011;10(2):265\u2013271.", "ArticleIdList": ["PMC3828900", "24250353"]}, {"Citation": "Li Z., Li H., Zhao C., et al. Protective effect of notoginsenoside R1 on an APP/PS1 mouse model of Alzheimer's disease by up-regulating insulin degrading enzyme and inhibiting A\u03b2 accumulation. CNS & neurological disorders drug targets . 2015;14(3):360\u2013369. doi: 10.2174/1871527314666150225141521.", "ArticleIdList": ["10.2174/1871527314666150225141521", "25714973"]}, {"Citation": "Murata K., Iida D., Ueno Y., et al. Novel polyacetylene derivatives and their inhibitory activities on acetylcholinesterase obtained from Panax ginseng roots. Journal of natural medicines . 2017;71(1):114\u2013122. doi: 10.1007/s11418-016-1036-7.", "ArticleIdList": ["10.1007/s11418-016-1036-7", "27568312"]}, {"Citation": "Kim C., Ryu H., Lee S., et al. Neuroprotective effect and antioxidant potency of fermented cultured wild ginseng root extracts of Panax ginseng C.A. Meyer in mice. Molecules (Basel, Switzerland) . 2021;26(10):p. 3001. doi: 10.3390/molecules26103001.", "ArticleIdList": ["10.3390/molecules26103001", "PMC8158381", "34070099"]}, {"Citation": "Yang Y., Liang X., Jin P., et al. Screening and determination for potential acetylcholinesterase inhibitory constituents from ginseng stem-leaf saponins using ultrafiltration (UF)\u2010LC\u2010ESI\u2010MS2. Phytochemical analysis : PCA . 2019;30(1):26\u201333. doi: 10.1002/pca.2787.", "ArticleIdList": ["10.1002/pca.2787", "30159954"]}, {"Citation": "Moss D., Perez R. Anti-neurodegenerative benefits of acetylcholinesterase inhibitors in Alzheimer's disease: nexus of cholinergic and nerve growth factor dysfunction. Current Alzheimer research . 2021;18(13):1010\u20131022. doi: 10.2174/1567205018666211215150547.", "ArticleIdList": ["10.2174/1567205018666211215150547", "PMC8855657", "34911424"]}, {"Citation": "Li S., Liu C., Zhang Y., Tsao R. On-line coupling pressurised liquid extraction with two-dimensional counter current chromatography for isolation of natural acetylcholinesterase inhibitors from Astragalus membranaceus. Phytochemical analysis : PCA . 2021;32(4):640\u2013653. doi: 10.1002/pca.3012.", "ArticleIdList": ["10.1002/pca.3012", "33238329"]}, {"Citation": "Das A., Shanker G., Nath C., Pal R., Singh S., Singh H. A comparative study in rodents of standardized extracts of _Bacopa monniera_ and _Ginkgo biloba_ : Anticholinesterase and cognitive enhancing activities. Pharmacology, biochemistry, and behavior . 2002;73(4):893\u2013900. doi: 10.1016/S0091-3057(02)00940-1.", "ArticleIdList": ["10.1016/S0091-3057(02)00940-1", "12213536"]}, {"Citation": "Zhang J., Wang J., Zhou G., et al. Studies of the anti-amnesic effects and mechanisms of single and combined use of donepezil and ginkgo ketoester tablet on scopolamine-induced memory impairment in mice. Oxidative medicine and cellular longevity . 2019;2019:16. doi: 10.1155/2019/8636835.8636835", "ArticleIdList": ["10.1155/2019/8636835", "PMC6398023", "30911351"]}, {"Citation": "Yang P., Cai X., Zhou K., Lu C., Chen W. A Novel Oil-Body Nanoemulsion Formulation of Ginkgolide B: Pharmacokinetics Study and _In Vivo_ Pharmacodynamics Evaluations. Journal of pharmaceutical sciences . 2014;103(4):1075\u20131084. doi: 10.1002/jps.23866.", "ArticleIdList": ["10.1002/jps.23866", "24496859"]}, {"Citation": "Singh S., Dwivedi H., Gunjan S., Chauhan B., Pandey S., Tripathi R. Potential role of arteether on N-methyl-D-aspartate (NMDA) receptor expression in experimental cerebral malaria mice and extension of their survival. Parasitology . 2019;146(12):1571\u20131577. doi: 10.1017/S0031182019000878.", "ArticleIdList": ["10.1017/S0031182019000878", "31244453"]}, {"Citation": "Kim S., Kim T., Ahn K., Park W., Nah S., Rhim H. Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochemical and biophysical research communications . 2004;323(2):416\u2013424. doi: 10.1016/j.bbrc.2004.08.106.", "ArticleIdList": ["10.1016/j.bbrc.2004.08.106", "15369768"]}, {"Citation": "Ryoo N., Rahman M., Hwang H., et al. Ginsenoside Rk1 is a novel inhibitor of NMDA receptors in cultured rat hippocampal neurons. Journal of ginseng research . 2020;44(3):490\u2013495. doi: 10.1016/j.jgr.2019.04.002.", "ArticleIdList": ["10.1016/j.jgr.2019.04.002", "PMC7195591", "32372871"]}, {"Citation": "Xie Z., Shi M., Zhang C., Zhao H., Hui H., Zhao G. Ginsenoside Rd protects against cerebral ischemia-reperfusion injury via decreasing the expression of the NMDA receptor 2B subunit and its phosphorylated product. Neurochemical research . 2016;41(8):2149\u20132159. doi: 10.1007/s11064-016-1930-0.", "ArticleIdList": ["10.1007/s11064-016-1930-0", "27165636"]}, {"Citation": "Essawy A., Abd Elkader H., Khamiss O., Eweda S., Abdou H. Therapeutic effects of astragaloside IV andAstragalus spinosus saponinsagainst bisphenol A-induced neurotoxicity and DNA damage in rats. PeerJ . 2021;9, article e11930 doi: 10.7717/peerj.11930.", "ArticleIdList": ["10.7717/peerj.11930", "PMC8359804", "34434659"]}, {"Citation": "Liu Y., Ding S., Luan Y., Zhu Z., Cai Y., Liu Y. Ginkgo biloba extracts inhibit post-ischemic LTP through attenuating EPSCs in rat hippocampus. Metabolic brain disease . 2021;36(8):2299\u20132311. doi: 10.1007/s11011-021-00830-4.", "ArticleIdList": ["10.1007/s11011-021-00830-4", "34463942"]}, {"Citation": "Kuo L., Song Y., Yao C., et al. Ginkgolide A prevents the amyloid-\u03b2-induced depolarization of cortical neurons. Journal of agricultural and food chemistry . 2019;67(1):81\u201389. doi: 10.1021/acs.jafc.8b04514.", "ArticleIdList": ["10.1021/acs.jafc.8b04514", "30541279"]}, {"Citation": "Esteras N., Abramov A. Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology. Cells . 2020;9(9):p. 2135. doi: 10.3390/cells9092135.", "ArticleIdList": ["10.3390/cells9092135", "PMC7564294", "32967303"]}, {"Citation": "Depp C., Bas-Orth C., Schroeder L., Hellwig A., Bading H. Synaptic activity protects neurons against calcium-mediated oxidation and contraction of mitochondria during excitotoxicity. Antioxidants & redox signaling . 2018;29(12):1109\u20131124. doi: 10.1089/ars.2017.7092.", "ArticleIdList": ["10.1089/ars.2017.7092", "28990420"]}, {"Citation": "Adam-Vizi V., Starkov A. Calcium and mitochondrial reactive oxygen species generation: how to read the facts. Journal of Alzheimer's disease : JAD . 2010;20(s2):S413\u2013S426. doi: 10.3233/JAD-2010-100465.", "ArticleIdList": ["10.3233/JAD-2010-100465", "PMC3056350", "20421693"]}, {"Citation": "Huang J., Ma L., Yang Y., et al. Chloroform Extract of Artemisia annua L. Relaxes Mouse Airway Smooth Muscle. eCAM . 2017;2017, article 9870414:1\u201312. doi: 10.1155/2017/9870414.", "ArticleIdList": ["10.1155/2017/9870414", "PMC5702405", "29259649"]}, {"Citation": "Qiao G., Li S., Yang B., Li B. Inhibitory effects of artemisinin on voltage-gated ion channels in intact nodose ganglion neurones of adult rats. Basic & clinical pharmacology & toxicology . 2007;100(4):217\u2013224. doi: 10.1111/j.1742-7843.2006.00009.x.", "ArticleIdList": ["10.1111/j.1742-7843.2006.00009.x", "17371525"]}, {"Citation": "Kim S., Nah S., Rhim H. Neuroprotective effects of ginseng saponins against L-type Ca2+ channel-mediated cell death in rat cortical neurons. Biochemical and biophysical research communications . 2008;365(3):399\u2013405. doi: 10.1016/j.bbrc.2007.10.048.", "ArticleIdList": ["10.1016/j.bbrc.2007.10.048", "18023426"]}, {"Citation": "Lee J., Jeong S., Kim J., Lee B., Yoon I., Lee J., et al. Effects of ginsenosides and their metabolites on voltage-dependent Ca(2+) channel subtypes. Molecules and cells . 2006;21(1):52\u201362.", "ArticleIdList": ["16511347"]}, {"Citation": "Kim H., Lee B., Choi S., et al. Gintonin stimulates gliotransmitter release in cortical primary astrocytes. Neuroscience letters . 2015;603:19\u201324. doi: 10.1016/j.neulet.2015.07.012.", "ArticleIdList": ["10.1016/j.neulet.2015.07.012", "26191656"]}, {"Citation": "Lin Z., Chen L., Zhang J., et al. Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons. Acta pharmacologica Sinica . 2012;33(4):438\u2013444. doi: 10.1038/aps.2011.181.", "ArticleIdList": ["10.1038/aps.2011.181", "PMC4003359", "22407229"]}, {"Citation": "Zhao M., Lian W., Li Z., et al. Astragaloside IV inhibits membrane Ca2+ current but enhances sarcoplasmic reticulum Ca2+ release. The American journal of Chinese medicine . 2017;45(4):863\u2013877. doi: 10.1142/S0192415X1750046X.", "ArticleIdList": ["10.1142/S0192415X1750046X", "28595501"]}, {"Citation": "Butterfield D. A. Perspectives on oxidative stress in Alzheimer's disease and predictions of future research emphases. Journal of Alzheimer's Disease . 2018;64(s1):S469\u2013S479. doi: 10.3233/JAD-179912.", "ArticleIdList": ["10.3233/JAD-179912", "29504538"]}, {"Citation": "Cecerska-Hery\u0107 E., Polikowska A., Serwin N., et al. Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review. Neurochemistry international . 2022;153, article 105269 doi: 10.1016/j.neuint.2021.105269.", "ArticleIdList": ["10.1016/j.neuint.2021.105269", "34971747"]}, {"Citation": "Santos J. R., Gois A. M., Mendonca D. M. F., Freire M. A. M. Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer's disease. Frontiers in aging neuroscience . 2014;6:p. 206. doi: 10.3389/fnagi.2014.00206.", "ArticleIdList": ["10.3389/fnagi.2014.00206", "PMC4147716", "25221506"]}, {"Citation": "Goshtasbi H., Pakchin P., Movafeghi A., et al. Impacts of oxidants and antioxidants on the emergence and progression of Alzheimer's disease. Neurochemistry international . 2022;153, article 105268 doi: 10.1016/j.neuint.2021.105268.", "ArticleIdList": ["10.1016/j.neuint.2021.105268", "34954260"]}, {"Citation": "Jin X., Guo J., Wang L., et al. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: a comprehensive review. European journal of medicinal chemistry . 2021;218, article 113401 doi: 10.1016/j.ejmech.2021.113401.", "ArticleIdList": ["10.1016/j.ejmech.2021.113401", "33831779"]}, {"Citation": "Weill J., Stuckens C., Hue V., Ponte C. Improvement in the interpretation of the LH-LH perfusion test. Archives francaises de pediatrie . 1989;46(2):p. 154.", "ArticleIdList": ["2660763"]}, {"Citation": "Liu M., Bai X., Yu S., et al. Ginsenoside Re inhibits ROS/ASK-1 dependent mitochondrial apoptosis pathway and activation of Nrf2-antioxidant response in beta-amyloid-challenged SH-SY5Y Cells. Molecules . 2019;24(15):p. 2687. doi: 10.3390/molecules24152687.", "ArticleIdList": ["10.3390/molecules24152687", "PMC6696356", "31344860"]}, {"Citation": "Yang Q., Lin J., Zhang H., et al. Ginsenoside compound K regulates amyloid \u03b2 via the Nrf2/Keap1 signaling pathway in mice with scopolamine hydrobromide-induced memory impairments. Journal of molecular neuroscience : MN . 2019;67(1):62\u201371. doi: 10.1007/s12031-018-1210-3.", "ArticleIdList": ["10.1007/s12031-018-1210-3", "30535776"]}, {"Citation": "Wang L., He J., Wang L., Gu Y., Fan H., Tian H. Neuroprotective effect of ginsenoside Rb-1 on a rat model of Alzheimer's disease. Zhonghua yi xue za zhi . 2020;100(31):2462\u20132466. doi: 10.3760/cma.j.cn112137-202000123-00151.", "ArticleIdList": ["10.3760/cma.j.cn112137-202000123-00151", "32819064"]}, {"Citation": "Yazicio\u011flu A., Yara\u015f S., Yurdalan A. Dentinal dysplasia (report of a case) The Journal of the Dental Faculty of Ankara University . 1986;13(1-2-3):219\u2013226.", "ArticleIdList": ["3505445"]}, {"Citation": "Sun Q., Jia N., Wang W., Jin H., Xu J., Hu H. Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening. PloS one . 2014;9(6, article e98866) doi: 10.1371/journal.pone.0098866.", "ArticleIdList": ["10.1371/journal.pone.0098866", "PMC4048237", "24905226"]}, {"Citation": "Zhang Y., Kong W., Chai X. Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of Alzheimer's disease mice. Neural regeneration research . 2018;13(4):731\u2013736. doi: 10.4103/1673-5374.230302.", "ArticleIdList": ["10.4103/1673-5374.230302", "PMC5950686", "29722328"]}, {"Citation": "Onyango I., Dennis J., Khan S. Mitochondrial dysfunction in Alzheimer's disease and the rationale for bioenergetics based therapies. Aging and disease . 2016;7(2):201\u2013214. doi: 10.14336/AD.2015.1007.", "ArticleIdList": ["10.14336/AD.2015.1007", "PMC4809610", "27114851"]}, {"Citation": "Zhou L., Zhu X. Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. The Journal of pharmacology and experimental therapeutics . 2000;293(3):982\u2013988.", "ArticleIdList": ["10869401"]}, {"Citation": "Shi C., Zhao L., Zhu B., et al. Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against \u03b2-amyloid peptide-induced toxicity in SH- SY5Y cells. Chemico-biological interactions . 2009;181(1):115\u2013123. doi: 10.1016/j.cbi.2009.05.010.", "ArticleIdList": ["10.1016/j.cbi.2009.05.010", "19464278"]}, {"Citation": "Shi C., Liu J., Wu F., Yew D. Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice. International journal of molecular sciences . 2010;11(1):107\u2013123. doi: 10.3390/ijms11010107.", "ArticleIdList": ["10.3390/ijms11010107", "PMC2820992", "20162004"]}, {"Citation": "Inestrosa N., Varela-Nallar L. Wnt signaling in the nervous system and in Alzheimer's disease. Journal of molecular cell biology . 2014;6(1):64\u201374. doi: 10.1093/jmcb/mjt051.", "ArticleIdList": ["10.1093/jmcb/mjt051", "24549157"]}, {"Citation": "Jia L., Pi\u00f1a-Crespo J., Li Y. Restoring Wnt/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer's disease. Molecular brain . 2019;12(1):p. 104. doi: 10.1186/s13041-019-0525-5.", "ArticleIdList": ["10.1186/s13041-019-0525-5", "PMC6894260", "31801553"]}, {"Citation": "Li X., Ma W., Wang X., et al. Notoginsenoside R1 promotes the growth of neonatal rat cortical neurons via the Wnt/\u03b2-catenin signaling pathway. CNS & neurological disorders drug targets . 2018;17(7):547\u2013556. doi: 10.2174/1871527317666180711093538.", "ArticleIdList": ["10.2174/1871527317666180711093538", "29992896"]}, {"Citation": "Deng S., Wong C., Lai H., Wong A. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/\u03b2-catenin signaling and epithelial-to-mesenchymal transition. Oncotarget . 2017;8(16):25897\u201325914. doi: 10.18632/oncotarget.13071.", "ArticleIdList": ["10.18632/oncotarget.13071", "PMC5432225", "27825116"]}, {"Citation": "Zhou T., Zu G., Zhang X., et al. Neuroprotective effects of ginsenoside Rg1 through the Wnt/\u03b2-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease. Neuropharmacology . 2016;101:480\u2013489. doi: 10.1016/j.neuropharm.2015.10.024.", "ArticleIdList": ["10.1016/j.neuropharm.2015.10.024", "26525190"]}, {"Citation": "Sun L., Zhang H., Wang W., et al. Astragaloside IV exerts cognitive benefits and promotes hippocampal neurogenesis in stroke mice by downregulating interleukin-17 expression via Wnt pathway. Frontiers in pharmacology . 2020;11:p. 421. doi: 10.3389/fphar.2020.00421.", "ArticleIdList": ["10.3389/fphar.2020.00421", "PMC7147333", "32317974"]}, {"Citation": "Li M., Chang C., Han Y., Liao C., Yu J., Wang T. Ginkgolide B promotes neuronal differentiation through the Wnt/\u03b2-catenin pathway in neural stem cells of the postnatal mammalian subventricular zone. Scientific reports . 2018;8(1):p. 14947. doi: 10.1038/s41598-018-32960-8.", "ArticleIdList": ["10.1038/s41598-018-32960-8", "PMC6175824", "30297722"]}, {"Citation": "Liu M., Guo J., Wang J., Zhang L., Pang T., Liao H. Correction to: Bilobalide induces neuronal differentiation of P19 embryonic carcinoma cells via activating Wnt/\u03b2-catenin pathway. Cellular and molecular neurobiology . 2020;40(4):663\u2013665. doi: 10.1007/s10571-019-00754-9.", "ArticleIdList": ["10.1007/s10571-019-00754-9", "31696374"]}, {"Citation": "Brunet A., Datta S., Greenberg M. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Current opinion in neurobiology . 2001;11(3):297\u2013305. doi: 10.1016/S0959-4388(00)00211-7.", "ArticleIdList": ["10.1016/S0959-4388(00)00211-7", "11399427"]}, {"Citation": "Kumar M., Bansal N. Implications of phosphoinositide 3-kinase-Akt (PI3K-Akt) pathway in the pathogenesis of Alzheimer's disease. Molecular neurobiology . 2022;59(1):354\u2013385. doi: 10.1007/s12035-021-02611-7.", "ArticleIdList": ["10.1007/s12035-021-02611-7", "34699027"]}, {"Citation": "Wang H., Quirion R., Little P. J., et al. Forkhead box O transcription factors as possible mediators in the development of major depression. Neuropharmacology . 2015;99:527\u2013537. doi: 10.1016/j.neuropharm.2015.08.020.", "ArticleIdList": ["10.1016/j.neuropharm.2015.08.020", "26279492"]}, {"Citation": "Rai S., Dilnashin H., Birla H., et al. The role of PI3K/Akt and ERK in neurodegenerative disorders. Neurotoxicity research . 2019;35(3):775\u2013795. doi: 10.1007/s12640-019-0003-y.", "ArticleIdList": ["10.1007/s12640-019-0003-y", "30707354"]}, {"Citation": "Long H., Cheng Y., Zhou Z., Luo H., Wen D., Gao L. PI3K/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer's disease and Parkinson's disease. Frontiers in pharmacology . 2021;12, article 648636 doi: 10.3389/fphar.2021.648636.", "ArticleIdList": ["10.3389/fphar.2021.648636", "PMC8082498", "33935751"]}, {"Citation": "Yates S., Zafar A., Hubbard P., et al. Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease. Acta neuropathologica communications . 2013;1(1):p. 3. doi: 10.1186/2051-5960-1-3.", "ArticleIdList": ["10.1186/2051-5960-1-3", "PMC3776211", "24252508"]}, {"Citation": "Hernandez F., Lucas J., Avila J. GSK3 and tau: two convergence points in Alzheimer's disease. Journal of Alzheimer's disease : JAD . 2012;33(s1):S141\u2013S144. doi: 10.3233/JAD-2012-129025.", "ArticleIdList": ["10.3233/JAD-2012-129025", "22710914"]}, {"Citation": "Hu S., Begum A., Jones M., et al. GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiology of disease . 2009;33(2):193\u2013206. doi: 10.1016/j.nbd.2008.10.007.", "ArticleIdList": ["10.1016/j.nbd.2008.10.007", "PMC4313761", "19038340"]}, {"Citation": "Fakhri S., Iranpanah A., Gravandi M., et al. Natural products attenuate PI3K/Akt/mTOR signaling pathway: a promising strategy in regulating neurodegeneration. Phytomedicine : international journal of phytotherapy and phytopharmacology . 2021;91, article 153664 doi: 10.1016/j.phymed.2021.153664.", "ArticleIdList": ["10.1016/j.phymed.2021.153664", "34391082"]}, {"Citation": "Zhang K., Yang Y., Ge H., et al. Artesunate promotes the proliferation of neural stem/progenitor cells and alleviates Ischemia-reperfusion injury through PI3K/Akt/FOXO-3a/p27kip1 signaling pathway. Aging . 2020;12(9):8029\u20138048. doi: 10.18632/aging.103121.", "ArticleIdList": ["10.18632/aging.103121", "PMC7244066", "32379706"]}, {"Citation": "Li H., Kang T., Qi B., et al. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer's disease. Journal of ethnopharmacology . 2016;179:162\u2013169. doi: 10.1016/j.jep.2015.12.020.", "ArticleIdList": ["10.1016/j.jep.2015.12.020", "26721223"]}, {"Citation": "Cui J., Shan R., Cao Y., Zhou Y., Liu C., Fan Y. Protective effects of ginsenoside Rg2 against memory impairment and neuronal death induced by A\u03b225-35 in rats. Journal of ethnopharmacology . 2021;266, article 113466 doi: 10.1016/j.jep.2020.113466.", "ArticleIdList": ["10.1016/j.jep.2020.113466", "33049344"]}, {"Citation": "Li L., Liu Z., Liu J., et al. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiology of disease . 2013;54:320\u2013328. doi: 10.1016/j.nbd.2013.01.002.", "ArticleIdList": ["10.1016/j.nbd.2013.01.002", "23321003"]}, {"Citation": "Jiang Y., Li S., Xie X., et al. Exploring the Mechanism of Panax notoginseng Saponins against Alzheimer\u2019s Disease by Network Pharmacology and Experimental Validation. Evidence-based complementary and alternative medicine : eCAM . 2021;2021, article 5730812:1\u201313. doi: 10.1155/2021/5730812.", "ArticleIdList": ["10.1155/2021/5730812", "PMC8739172", "35003304"]}, {"Citation": "Phu H., Thuan D., Nguyen T., Posadino A., Eid A., Pintus G. Herbal medicine for slowing aging and aging-associated conditions: efficacy, mechanisms and safety. Current vascular pharmacology . 2020;18(4):369\u2013393. doi: 10.2174/1570161117666190715121939.", "ArticleIdList": ["10.2174/1570161117666190715121939", "31418664"]}, {"Citation": "Zhang T., Li C., Zhang T., Wang M., Cui S., Huo Q. Mechanism of astragaloside IV alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica . 2021;46(24):6465\u20136473. doi: 10.19540/j.cnki.cjcmm.20210902.702.", "ArticleIdList": ["10.19540/j.cnki.cjcmm.20210902.702", "34994139"]}, {"Citation": "Zhang L., Liu Q., Lu L., Zhao X., Gao X., Wang Y. Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1\u03b1 accumulation via phosphatidylinositol 3-kinase/Akt pathway. The Journal of pharmacology and experimental therapeutics . 2011;338(2):485\u2013491. doi: 10.1124/jpet.111.180992.", "ArticleIdList": ["10.1124/jpet.111.180992", "21576377"]}, {"Citation": "Chen Y., Wang C., Hu M., et al. Effects of ginkgolide A on okadaic acid-induced tau hyperphosphorylation and the PI3K-Akt signaling pathway in N2a cells. Planta medica . 2012;78(12):1337\u20131341. doi: 10.1055/s-0032-1314965.", "ArticleIdList": ["10.1055/s-0032-1314965", "22700047"]}, {"Citation": "Bastianetto S., Zheng W.\u2010. H., Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. Journal of neurochemistry . 2000;74(6):2268\u20132277.", "ArticleIdList": ["10820186"]}, {"Citation": "Lejri I., Grimm A., Eckert A. Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathway. PloS one. . 2019;14(12, article e0225761)", "ArticleIdList": ["PMC6886765", "31790465"]}, {"Citation": "Albert-Gasc\u00f3 H., Ros-Bernal F., Castillo-G\u00f3mez E., Olucha-Bordonau F. MAP/ERK signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes. International journal of molecular sciences. International Journal of Molecular Sciences . 2020;21(12)", "ArticleIdList": ["PMC7352860", "32586047"]}, {"Citation": "Ostrowski P. P., Barszczyk A., Forstenpointner J., Zheng W., Feng Z.-P. Meta-analysis of serum insulin-like growth factor 1 in Alzheimer\u2019s disease. PLOS ONE . 2016;5:p. e0155733.", "ArticleIdList": ["PMC4881955", "27227831"]}, {"Citation": "Sharma V., Singh T., Singh S., Garg N., Dhiman S. Apoptotic pathways and Alzheimer's disease: probing therapeutic potential. Neurochemical research. . 2021;46(12):3103\u20133122.", "ArticleIdList": ["34386919"]}, {"Citation": "Lahiani A., Brand-Yavin A., Yavin E., Lazarovici P. Neuroprotective effects of bioactive compounds and MAPK pathway modulation in \"ischemia\"-stressed PC12 pheochromocytoma cells. Brain sciences. . 2018;8(2)", "ArticleIdList": ["PMC5836051", "29419806"]}, {"Citation": "Ahmed T., Zulfiqar A., Arguelles S., et al. Map kinase signaling as therapeutic target for neurodegeneration. Pharmacological research . 2020;160, article 105090", "ArticleIdList": ["32707231"]}, {"Citation": "Lee S., Youn K., Jun M. Major compounds of red ginseng oil attenuate A\u03b2-induced neuronal apoptosis and inflammation by modulating MAPK/NF-\u03baB pathway. Food & function . 2018;9(8):4122\u20134134.", "ArticleIdList": ["30014084"]}, {"Citation": "Liu J., He J., Huang L., Dou L., Wu S., Yuan Q. Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth. Neural regeneration research . 2014;9(9):943\u2013950.", "ArticleIdList": ["PMC4146219", "25206916"]}, {"Citation": "Yang L., Jiang Y., Shi L., et al. AMPK: potential therapeutic target for Alzheimer's disease. Current protein & peptide science. . 2020;21(1):66\u201377.", "ArticleIdList": ["31424367"]}, {"Citation": "Ryder J., Su Y., Ni B. Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations. Cellular signalling. . 2004;16(2):187\u2013200.", "ArticleIdList": ["14636889"]}, {"Citation": "Sengupta A., Kabat J., Novak M., Wu Q., Grundke-Iqbal I., Iqbal K. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Archives of biochemistry and biophysics. . 1998;357(2):299\u2013309.", "ArticleIdList": ["9735171"]}, {"Citation": "Johnson G., Stoothoff W. Tau phosphorylation in neuronal cell function and dysfunction. Journal of cell science . 2004;117:5721\u20135729.", "ArticleIdList": ["15537830"]}, {"Citation": "Zeng Y. Q., Chen X. C., Zhu Y. G., et al. Ginsenoside Rbl attenuates beta-amyloid peptide25-35 -induced tau hyperphosphorylation in cortical neurons. Yao xue xue bao= Acta Pharmaceutica Sinica . 2005;40(3):225\u2013230.", "ArticleIdList": ["15952593"]}, {"Citation": "Wang J., Ding Y., Zhuang L., Wang Z., Xiao W., Zhu J. Ginkgolide B-induced AMPK pathway activation protects astrocytes by regulating endoplasmic reticulum stress, oxidative stress and energy metabolism induced by A\u03b21-42. Molecular medicine reports . 2021;23(6)", "ArticleIdList": ["PMC8072312", "33880582"]}, {"Citation": "Kwon K., Lee E., Cho K., Cho D., Shin C., Han S. Ginkgo biloba extract (Egb761) attenuates zinc-induced tau phosphorylation at Ser262 by regulating GSK3\u03b2 activity in rat primary cortical neurons. Food & function . 2015;6(6):2058\u20132067.", "ArticleIdList": ["26032477"]}, {"Citation": "Shi C., Zheng D., Wu F., Liu J., Xu J. The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3\u03b2 pathway mediates bilobalide-induced reduction in amyloid \u03b2-peptide. Neurochemical research . 2012;37(2):298\u2013306.", "ArticleIdList": ["21952928"]}, {"Citation": "Doens D., Fern\u00e1ndez P. Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer's disease pathogenesis. Journal of neuroinflammation . 2014;11:p. 48.", "ArticleIdList": ["PMC3975152", "24625061"]}, {"Citation": "Chiarini A., Armato U., Hu P., Dal Pr\u00e0 I. Danger-sensing/patten recognition receptors and neuroinflammation in Alzheimer's disease. International journal of molecular sciences . 2020;21(23)", "ArticleIdList": ["PMC7731137", "33261147"]}, {"Citation": "Yang J., Wise L., Fukuchi K. TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer's disease. Frontiers in immunology . 2020;11:p. 724.", "ArticleIdList": ["PMC7190872", "32391019"]}, {"Citation": "Jha N., Jha S., Kar R., Nand P., Swati K., Goswami V. Nuclear factor-kappa \u03b2 as a therapeutic target for Alzheimer's disease. Journal of neurochemistry . 2019;150(2):113\u2013137.", "ArticleIdList": ["30802950"]}, {"Citation": "T\u00f3bon-Velasco J., Cuevas E., Torres-Ramos M. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS & neurological disorders drug targets . 2014;13(9):1615\u20131626.", "ArticleIdList": ["25106630"]}, {"Citation": "Kempuraj D., Thangavel R., Natteru P. A., et al. Neuroinflammation induces neurodegeneration. Journal of neurology, neurosurgery and spine. . 2016;1(1)", "ArticleIdList": ["PMC5260818", "28127589"]}, {"Citation": "Shi C., Li H., Yang Y., Hou L. Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives. Mediators of inflammation . 2015;2015:7.435713", "ArticleIdList": ["PMC4415672", "25960615"]}, {"Citation": "Wang Y., Liu J., Zhang Z., Bi P., Qi Z., Zhang C. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease. Neuroscience letters . 2011;487(1):70\u201372.", "ArticleIdList": ["20933058"]}, {"Citation": "Zhang Z., Wang X., Zhang D., Liu Y., Li L. Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease. Aging . 2019;11(2):536\u2013548.", "ArticleIdList": ["PMC6366989", "30684442"]}, {"Citation": "Ghoneim M., Abdallah D., Shebl A., El-Abhar H. The interrupted cross-talk of inflammatory and oxidative stress trajectories signifies the effect of artesunate against hepatic ischemia/reperfusion-induced inflammasomopathy. Toxicology and applied pharmacology . 2020;409, article 115309", "ArticleIdList": ["33130049"]}, {"Citation": "Tan X., Gu J., Zhao B., et al. Ginseng improves cognitive deficit via the RAGE/NF-\u03baB pathway in advanced glycation end product-induced rats. Journal of ginseng research . 2015;39(2):116\u2013124.", "ArticleIdList": ["PMC4452525", "26045684"]}, {"Citation": "Li W., Wang S., Wang H., et al. Astragaloside IV prevents memory impairment in D-galactose-induced aging rats via the AGEs/RAGE/ NF-\u03baB axis. Archives of medical research . 2022;53(1):20\u201328.", "ArticleIdList": ["34217517"]}, {"Citation": "Yan F., Zheng Y., Zhao F. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Acta neuropathologica . 2008;116(5):529\u2013535.", "ArticleIdList": ["18830615"]}, {"Citation": "Wan W.-b., Cao L., Liu L.-m., et al. EGb761 provides a protective effect against A\u03b21-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model. PloS one . 2014;9(11, article e113126)", "ArticleIdList": ["PMC4245095", "25426944"]}, {"Citation": "Kim M., Bang J., Lee J., Han J., Baik T., Jeon W. Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system. Phytomedicine : international journal of phytotherapy and phytopharmacology . 2016;23(12):1356\u20131364.", "ArticleIdList": ["27765355"]}, {"Citation": "Lu M., Chen C., Lee L., Lin T., Kuo C. N(6)-(2-Hydroxyethyl)adenosine in the medicinal mushroom Cordyceps cicadae attenuates lipopolysaccharide-stimulated pro-inflammatory responses by suppressing TLR4-mediated NF-\u03baB signaling pathways. Journal of natural products . 2015;78(10):2452\u20132460.", "ArticleIdList": ["26394068"]}, {"Citation": "Zhao B., Liu Y., Gao X., Zhai H., Guo J., Wang X. Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signalling transduction factors in the NG108-15 murine neuroglial cell line. Molecules (Basel, Switzerland) . 2014;19(10):16925\u201316936.", "ArticleIdList": ["PMC6271333", "25340298"]}, {"Citation": "Yu J., Guo M., Li Y., et al. Astragaloside IV protects neurons from microglia-mediated cell damage through promoting microglia polarization. Folia neuropathologica . 2019;57(2):170\u2013181.", "ArticleIdList": ["31556576"]}, {"Citation": "Li X., Huang L., Liu G., et al. Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-\u03baB pathway in rats. Journal of ethnopharmacology . 2020;249, article 112365", "ArticleIdList": ["31678414"]}, {"Citation": "Huang L., Shi Y., Zhao L. viaGinkgolide B alleviates learning and memory impairment in rats with vascular dementia by reducing neuroinflammation regulating NF-\u03baB pathway. Frontiers in pharmacology . 2021;12, article 676392", "ArticleIdList": ["PMC8245850", "34220511"]}, {"Citation": "Shi J.\u2010. Q., Zhang C.\u2010. C., Sun X.\u2010. L., et al. Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-\u03baB and NLRP3 inflammasome activation. CNS neuroscience & therapeutics . 2013;19(4):262\u2013268.", "ArticleIdList": ["PMC6493386", "23406388"]}, {"Citation": "Severini C., Barbato C., Di Certo M. G., et al. Alzheimer's disease: new concepts on the role of autoimmunity and NLRP3 inflammasome in the pathogenesis of the disease. Current neuropharmacology . 2021;19(4):498\u2013512.", "ArticleIdList": ["PMC8206463", "32564756"]}, {"Citation": "Shi Y., Wang H., Zheng M., Xu W., Yang Y., Shi F. Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly. FASEB journal : official publication of the Federation of American Societies for Experimental Biology . 2020;34(1):208\u2013221.", "ArticleIdList": ["31914640"]}, {"Citation": "Gao Y., Li J., Wang J., et al. Ginsenoside Rg1 prevent and treat inflammatory diseases: a review. International immunopharmacology . 2020;87, article 106805", "ArticleIdList": ["32731179"]}, {"Citation": "Li M., Li H., Fang F., Deng X., Ma S. Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms. Neuroscience letters . 2017;639:114\u2013119.", "ArticleIdList": ["28011393"]}, {"Citation": "Liu F., Gao Q., Wang D., Zhang Z. Effects of GBE50 on LPS/ATP induced NLRP3 inflammasome activation in primary rat microglia. China Journal of Chinese Materia Medica . 2018;43(16):3346\u20133352.", "ArticleIdList": ["30200740"]}, {"Citation": "Chen A., Xu Y., Yuan J. Ginkgolide B ameliorates NLRP3 inflammasome activation after hypoxic-ischemic brain injury in the neonatal male rat. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience . 2018;69:106\u2013111.", "ArticleIdList": ["30030129"]}, {"Citation": "da Costa I. M., de Moura Freire M. A., de Paiva Cavalcanti J. R., et al. Supplementation with Curcuma longa reverses neurotoxic and behavioral damage in models of Alzheimer's disease: a systematic review. Current neuropharmacology . 2019;17(5):406\u2013421.", "ArticleIdList": ["PMC6520588", "29338678"]}, {"Citation": "Subedi L., Gaire B. P. Neuroprotective effects of curcumin in cerebral ischemia: cellular and molecular mechanisms. ACS Chemical Neuroscience . 2021;12(14):2562\u20132572.", "ArticleIdList": ["34251185"]}, {"Citation": "Nayak V. S., Kumar N., D'Souza A. S., Nayak S. S., Cheruku S. P., Pai K. S. R. The effects of Mucuna pruriens extract on histopathological and biochemical features in the rat model of ischemia. Neuroreport . 2017;28(18):1195\u20131201.", "ArticleIdList": ["28953092"]}, {"Citation": "Neta F. I., Costa I. M., Lima F. O. V., et al. Effects of Mucuna pruriens (L.) supplementation on experimental models of Parkinson's disease: a systematic review. Pharmacognosy Reviews . 2018;12(23):78\u201384."}, {"Citation": "Chhetri J., Chan P., Vellas B., Touchon J., Gauthier S. Report from the first Clinical Trials on Alzheimer's Disease (CTAD) Asia-China 2018 : bringing together global leaders. The journal of prevention of Alzheimer's disease . 2019;6(2):144\u2013147.", "ArticleIdList": ["30756122"]}, {"Citation": "Ude C., Schubert-Zsilavecz M., Wurglics M. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clinical pharmacokinetics . 2013;52(9):727\u2013749.", "ArticleIdList": ["23703577"]}, {"Citation": "Xu Y., Zhao M., Zhou D., Zheng T., Zhang H. The application of multifunctional nanomaterials in Alzheimer's disease: a potential theranostics strategy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie . 2021;137, article 111360", "ArticleIdList": ["33582451"]}, {"Citation": "Kim H., Lee J. H., Kim J. E., et al. Micro-/nano-sized delivery systems of 1511 ginsenosides for improved systemic bioavailability. Journal of ginseng research . 2018;42(3):361\u2013369.", "ArticleIdList": ["PMC6026383", "29983618"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "3"}, {"Year": "2022", "Month": "5", "Day": "20"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "2", "Minute": "4"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["35746960", "PMC9213169", "10.1155/2022/3777021"]}}], "PubmedBookArticle": []}